The federal agency began requiring institutions to provide upfront pricing for radiology services on Jan. 1, but many have ignored the mandate, officials said. 

The National Cancer Institute at one point had considered quashing the Tomosynthesis Mammography Imaging Screening Trial, but organizers are optimistic after recent upticks. 

The American College of Radiology Association is providing the initial $225,000 with the goal of safeguarding patients’ access to physician-led care. 

Provider groups can potentially use subsidiaries for different markets or different payer arrangements based on the new guidance, experts advised. 

Advocates are pleased with plans to delay the punitive phase of the appropriate-use criteria program, but concerned about cuts to the conversion factor.

ACR disagrees with treating each provider contract equally, regardless of the practice size and market share, when determining the median rate. 

Radiology advocates said late Thursday that they're conducting a "thorough review" of the new rule, which will take effect on Jan. 1, 2022. 

ACR on Thursday urged the specialty to stay “vigilant” in ensuring that physician extenders remain under the watch of a trained professional.